These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38856835)

  • 1. Anticancer potential and structure activity studies of purine and pyrimidine derivatives: an updated review.
    Manna T; Maji S; Maity M; Debnath B; Panda S; Khan SA; Nath R; Akhtar MJ
    Mol Divers; 2024 Jun; ():. PubMed ID: 38856835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrimidine: An elite heterocyclic leitmotif in drug discovery-synthesis and biological activity.
    Nadar S; Khan T
    Chem Biol Drug Des; 2022 Dec; 100(6):818-842. PubMed ID: 34914188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic Strategies of Pyrimidine-Based Scaffolds as Aurora Kinase and Polo-like Kinase Inhibitors.
    Jadhav M; Sankhe K; Bhandare RR; Edis Z; Bloukh SH; Khan TA
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Developments and Future Perspectives of Purine Derivatives as a Promising Scaffold in Drug Discovery.
    Rana N; Grover P; Singh H
    Curr Top Med Chem; 2024; 24(6):541-579. PubMed ID: 38288806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
    Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
    Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range.
    Mavrova AT; Dimov S; Yancheva D; Rangelov M; Wesselinova D; Naydenova E
    Anticancer Agents Med Chem; 2022; 22(6):1201-1212. PubMed ID: 34315388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Development of Pyrimidine-Containing Antimicrobial Agents.
    Zhuang J; Ma S
    ChemMedChem; 2020 Oct; 15(20):1875-1886. PubMed ID: 32797654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cancer pyrimidines in diverse scaffolds: a review of patent literature.
    Kaur R; Kaur P; Sharma S; Singh G; Mehndiratta S; Bedi PM; Nepali K
    Recent Pat Anticancer Drug Discov; 2015; 10(1):23-71. PubMed ID: 25230072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview of the Synthetic Route to the Marketed Formulations of Pyrimidine: A Review.
    Kumar A; Siwach A; Verma P
    Mini Rev Med Chem; 2022; 22(6):884-903. PubMed ID: 34629043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Activity Relationships of Pyrimidine Derivatives and their Biological Activity - A Review.
    Natarajan R; Anthoni Samy HN; Sivaperuman A; Subramani A
    Med Chem; 2022; 19(1):10-30. PubMed ID: 35579151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and evaluation of purine and pyrimidine-based
    Park SY; Gowda Saralamma VV; Nale SD; Kim CJ; Jo YS; Baig MH; Cho J
    Heliyon; 2024 Apr; 10(7):e28495. PubMed ID: 38617914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Route to the Synthesis of Novel Pyrazolo[1,5-a]pyrimidines and Evaluation of their Antimicrobial Activity as RNA Polymerase Inhibitors.
    Abdallah AEM; Elgemeie GH
    Med Chem; 2022; 18(9):926-948. PubMed ID: 35236270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Appraisal on Synthetic and Medicinal Aspects of Fused Pyrimidines as Anti Neoplastic Agents.
    Rani I; Kaur N; Goyal A; Sharma M
    Anticancer Agents Med Chem; 2023; 23(5):525-561. PubMed ID: 35786337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
    Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
    Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology.
    El Ashry ESH; Awad LF; Teleb M; Ibrahim NA; Abu-Serie MM; Abd Al Moaty MN
    Bioorg Chem; 2020 Mar; 96():103616. PubMed ID: 32032847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrimidine-fused Derivatives: Synthetic Strategies and Medicinal Attributes.
    Joshi G; Nayyar H; Alex JM; Vishwakarma GS; Mittal S; Kumar R
    Curr Top Med Chem; 2016; 16(28):3175-3210. PubMed ID: 27150371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Patent Review of Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors as Anticancer Agents and their Other Therapeutic Applications (1999-2022).
    Gehlot P; Vyas VK
    Recent Pat Anticancer Drug Discov; 2024; 19(3):280-297. PubMed ID: 37070439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Anticancer Agents.
    Prachayasittikul S; Pingaew R; Worachartcheewan A; Sinthupoom N; Prachayasittikul V; Ruchirawat S; Prachayasittikul V
    Mini Rev Med Chem; 2017; 17(10):869-901. PubMed ID: 27670581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Oxazolo[5,4-
    Sochacka-Ćwikła A; Mączyński M; Czyżnikowska Ż; Wiatrak B; Jęśkowiak I; Czerski A; Regiec A
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Medicinal Chemist's Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents.
    Nehra B; Mathew B; Chawla PA
    Curr Top Med Chem; 2022; 22(6):493-528. PubMed ID: 35021975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.